Lisa Thompson advises companies, senior management, and their boards of directors, with a focus on the health care, life sciences and technology industries. She is a member of the firm’s Health Law Group and Data Privacy + Cybersecurity Team. She is also an arbitrator on the Commercial panel and the Health Care panel of the American Arbitration Association.
Health Care, Life Science and Technology Industries
Lisa represents domestic and international clients in the health care, life science and technology industries, including pharmaceutical companies, medical device manufacturers, biotechnology companies, hospital systems, academic medical centers, health information exchanges (HIEs) and technology services providers. In addition, she has represented third party administrators, pharmacy benefit managers, health plans, laboratories, physician practices, pharmacies and retail pharmacy chains, among others in these industries.
Lisa handles a range of matters, including corporate law and contracting, government investigations and audits, clinical research law, and matters involving Institutional Review Boards (IRBs). She has extensive experience representing clients on matters involving privacy and security including HIPAA, reimbursement, Medicare and Medicaid, state and federal surveys and termination actions, managed care disputes, pharmacy and compounding laws, fraud and abuse, Stark Law, anti-kickback, and federal program exclusions.
Lisa’s life sciences experience includes U.S. Food and Drug Administration (FDA) compliance and regulatory matters, product recalls and liability claims, FDA citizen petitions and appeals, labeling review, advertising and marketing compliance, drug and medical device reimbursement, clinical research agreements, Sunshine Act compliance, and commercial contracting. Her technology sector experience includes advising on privacy and security, software licensing, data use agreements, information exchange system agreements, and regulatory requirements.
She formerly served in-house as chief counsel for an international medical device manufacturer, as general counsel for a pharmacy benefit management company, and as corporate, privacy, and research counsel for a major academic medical center. She is a co-editor and contributor for the firm’s blog, Health Law Diagnosis.
More Legal and Business Bylines From Melissa (Lisa) Thompson
- Physician Self-Referral Law (Stark), Anti-Kickback Statute, and Beneficiary Inducement CMPs – HHS Releases Final Rules - (Posted On Saturday, November 21, 2020)
- CMS Finalizes 2021 End-Stage Renal Disease Prospective Payment System Rule Expanding Payments for In-Home Dialysis Equipment and Supplies - (Posted On Thursday, November 05, 2020)
- CMS Announces New Telehealth Services Covered by Medicare and Provides States with Medicaid and CHIP Telehealth Expansion Assistance - (Posted On Tuesday, October 20, 2020)
- CMS Proposes 2021 End Stage Renal Disease Prospective Payment System Rule - (Posted On Tuesday, July 07, 2020)
- OCR Reaches Early Case Resolutions with the State of Connecticut and a Private Hospital Regarding Rights of Persons with Disabilities to Have Reasonable Access to Support Persons in Hospital Settings During COVID-19 - (Posted On Thursday, June 11, 2020)
- CMS Proposes IPPS and LTCH PPS Payment and Policy Changes for FY 2021 - (Posted On Thursday, May 14, 2020)
- CMS Releases Additional Blanket Waivers in Response to COVID-19 Pandemic - (Posted On Wednesday, May 13, 2020)
- CMS Interim Rule Makes Sweeping Changes in Response to COVID-19 Public Health Emergency - (Posted On Friday, May 08, 2020)
- CMS Broadens Telehealth Access Across the Board, Including Audio-Only Telephone Services - (Posted On Tuesday, May 05, 2020)
- CMS Announces Merit-Based Incentive Payment for Clinicians Participating in COVID-19 Clinical Trial - (Posted On Wednesday, April 22, 2020)